Lista de obras - Dario Baratti - Dominio Público Uruguay

Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer.

artículo científico publicado en 2010

Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Advantages and limits

scientific article published on 01 April 1994

Bowel Complications in 203 Cases of Peritoneal Surface Malignancies Treated With Peritonectomy and Closed-Technique Intraperitoneal Hyperthermic Perfusion

artículo científico publicado en 2005

CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases

scientific article published on 01 October 2006

Carboplatin plus paclitaxel scheduling for advanced ovarian cancer.

artículo científico publicado en 2014

Chordoma: natural history and results in 28 patients treated at a single institution.

artículo científico publicado en 2003

Circulating CA125 and diffuse malignant peritoneal mesothelioma

artículo científico publicado en 2009

Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

scientific article published on 06 December 2006

Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei.

artículo científico publicado en 2013

Colorectal Cancer Peritoneal Metastases: Second-look Laparotomy, Prophylactic HIPEC, or Both?

artículo científico publicado en 2016

Commment on the review entitled "A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer" by Chiva LM and Gonzalez-Martin A.

artículo científico publicado en 2015

Consensus statement on peritoneal mesothelioma.

artículo científico publicado en 2008

Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)

artículo científico publicado en 2010

Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan

scientific article published on 18 April 2006

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.

artículo científico publicado en 2011

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

artículo científico publicado en 2009

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology

artículo científico publicado en 2006

Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion

scientific article published on 01 March 2006

Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study.

artículo científico publicado en 2012

Diffuse malignant mesothelioma of the peritoneum

artículo científico publicado en 2005

Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

artículo científico publicado en 2008

Diffuse malignant peritoneal mesothelioma: Systematic review of clinical management and biological research ⬇️

artículo científico publicado el 31 de enero de 2011

Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).

artículo científico publicado en 2013

Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.

artículo científico publicado en 2008

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

artículo científico publicado en 2012

Effect of liver transplantation in cirrhotic diabetic patients.

artículo científico publicado en 1998

Epidural analgesia for cytoreductive surgery with peritonectomy and heated intraperitoneal chemotherapy

artículo científico publicado en 2015

Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution

artículo científico publicado en 2007

Experience with peritoneal mesothelioma at the Milan National Cancer Institute.

artículo científico publicado en 2010

FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma

artículo científico publicado en 2014

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

artículo científico publicado en 2016

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases

artículo científico publicado en 2016

Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy

artículo científico publicado en 2012

Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray

artículo científico publicado en 2015

Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity

article

Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy

artículo científico publicado en 2007

Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres

artículo científico publicado en 2012

Lymph node metastases in diffuse malignant peritoneal mesothelioma.

artículo científico publicado en 2009

Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma

scientific article published on 19 November 2019

Morbidity and quality of life following cytoreduction and HIPEC.

artículo científico publicado en 2007

Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy.

artículo científico publicado en 2008

Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei.

artículo científico publicado en 2014

Multicystic mesothelioma: Operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy

artículo científico publicado en 2018

Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

scientific article published on 15 September 2010

Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies.

artículo científico publicado en 2012

Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma

scientific article published on 01 July 2008

Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?

artículo científico publicado en 2010

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.

artículo científico publicado en 2003

Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei

Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases

artículo científico publicado en 2013

Post-absorptive and insulin-mediated muscle protein metabolism in liver-transplanted patients

artículo científico publicado en 2002

Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.

artículo científico publicado en 2014

Preoperative radiotherapy for resectable cancer of the middle-distal rectum: its effect on the primary lesion as determined by endorectal ultrasound using flexible echo colonoscope

scientific article published on 01 January 1996

Prevention and early treatment of peritoneal metastases from colorectal cancer: second-look laparotomy or prophylactic HIPEC?

artículo científico publicado en 2014

Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients.

artículo científico publicado en 2013

Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

artículo científico publicado en 2006

Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

artículo científico publicado en 2007

Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review

artículo científico publicado en 2016

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

artículo científico publicado en 1997

Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.

artículo científico publicado en 2016

Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

scientific article published on 28 November 2007

Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy

scientific article published on 01 February 2009

Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma.

artículo científico publicado en 2010

Renal-splenic shunt for infrahepatic caval occlusion after piggy-back liver transplantation

scientific article published on 01 January 1997

Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study.

artículo científico publicado en 2012

Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies.

scientific article published on September 2009

Technical aspects of cytoreductive surgery.

artículo científico publicado en 2008

The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis

artículo científico

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.

artículo científico publicado en 2014

The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus.

scientific article published on September 2008

The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

artículo científico publicado en 2015

The consensus statement on the locoregional treatment of abdominal sarcomatosis.

artículo científico publicado en 2008

The eligibility for local-regional treatment of peritoneal surface malignancy.

artículo científico publicado en 2008

The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs

artículo científico publicado en 2012

The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

artículo científico publicado en 2015

The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma.

artículo científico publicado en 2014

The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

artículo científico publicado en 2013

Toward the molecular dissection of peritoneal pseudomyxoma.

artículo científico publicado en 2016

Lista de obras de Dario Baratti

Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer.

Avidin-biotin system in radioimmunoguided surgery for colorectal cancer. Advantages and limits

Bowel Complications in 203 Cases of Peritoneal Surface Malignancies Treated With Peritonectomy and Closed-Technique Intraperitoneal Hyperthermic Perfusion

CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases

Carboplatin plus paclitaxel scheduling for advanced ovarian cancer.

Chordoma: natural history and results in 28 patients treated at a single institution.

Circulating CA125 and diffuse malignant peritoneal mesothelioma

Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei.

Colorectal Cancer Peritoneal Metastases: Second-look Laparotomy, Prophylactic HIPEC, or Both?

Commment on the review entitled "A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer" by Chiva LM and Gonzalez-Martin A.

Consensus statement on peritoneal mesothelioma.

Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)

Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology

Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion

Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study.

Diffuse malignant mesothelioma of the peritoneum

Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

Diffuse malignant peritoneal mesothelioma: Systematic review of clinical management and biological research ⬇️

Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).

Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Effect of liver transplantation in cirrhotic diabetic patients.

Epidural analgesia for cytoreductive surgery with peritonectomy and heated intraperitoneal chemotherapy

Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution

Experience with peritoneal mesothelioma at the Milan National Cancer Institute.

FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases

Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy

Immunohistochemical Evaluation of Minichromosome Maintenance Protein 7 (MCM7), Topoisomerase IIα, and Ki-67 in Diffuse Malignant Peritoneal Mesothelioma Patients Using Tissue Microarray

Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity

Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy

Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres

Lymph node metastases in diffuse malignant peritoneal mesothelioma.

Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma

Morbidity and quality of life following cytoreduction and HIPEC.

Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy.

Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei.

Multicystic mesothelioma: Operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy

Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies.

Multiple Mechanisms of Telomere Maintenance Exist and Differentially Affect Clinical Outcome in Diffuse Malignant Peritoneal Mesothelioma

Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?

Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.

Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei

Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases

Post-absorptive and insulin-mediated muscle protein metabolism in liver-transplanted patients

Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.

Preoperative radiotherapy for resectable cancer of the middle-distal rectum: its effect on the primary lesion as determined by endorectal ultrasound using flexible echo colonoscope

Prevention and early treatment of peritoneal metastases from colorectal cancer: second-look laparotomy or prophylactic HIPEC?

Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients.

Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.

Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy

Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma.

Renal-splenic shunt for infrahepatic caval occlusion after piggy-back liver transplantation

Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study.

Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies.

Technical aspects of cytoreductive surgery.

The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.

The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus.

The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

The consensus statement on the locoregional treatment of abdominal sarcomatosis.

The eligibility for local-regional treatment of peritoneal surface malignancy.

The importance of the learning curve and surveillance of surgical performance in peritoneal surface malignancy programs

The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma.

The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Toward the molecular dissection of peritoneal pseudomyxoma.